The Basics
- 15-amino-acid synthetic peptide (Body Protection Compound-157)
- 500 mcg per capsule · 60 capsules per bottle
- Oral format — no reconstitution or syringes
- Raw-material COA by BT Lab Testing (FTIR + HPLC)
Popular searches
BPC-157: 500 mcg Oral Capsules
A simple 60-count oral format for BPC-157 - pre-dosed capsules, no reconstitution, no syringes, and third-party raw-material COA verification.
- 500 mcg per capsule
- BT Lab Testing COA
- Room-temperature storage
Educational only. BPC-157 human oral-use data is limited. Not for use if pregnant, nursing, under 18, or on medication without professional guidance.
Key Takeaways (TL;DR)
Each bottle contains 60 capsules with 500 mcg BPC-157 per capsule.
The oral capsule format removes reconstitution, bacteriostatic water, syringes, and cold-chain handling.
The BPC-157 raw material used in this lot is verified by BT Lab Testing for identity, 100% HPLC purity, and 100% potency.
Evidence is strongest in preclinical models for tendon, ligament, gut-lining, angiogenesis, and inflammatory-response pathways.
Human oral-use data remains limited. Start conservatively and use professional guidance when appropriate.
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide modeled on a gastric peptide fragment. Nootropix BPC-157 capsules provide a pre-measured 500 mcg oral serving in a 60-count bottle.
Scientific Overview
Compound: BPC-157 is a 15-amino-acid peptide studied in preclinical models for nitric-oxide signaling, VEGFR2-Akt-eNOS activity, angiogenesis, and tissue-recovery pathways. Oral capsules offer a practical route for users who prefer a simple daily format over reconstituted peptide vials.
- Format: 500 mcg oral capsules, 60ct.
- Verification: BT Lab Testing confirmed the BPC-157 raw material used in this lot by FTIR and HPLC.
- Storage: room temperature, tightly closed, away from heat and moisture.
Informational only. Not medical advice.
This content is educational and not medical advice. BPC-157 is for adult use only. Human oral-use data is limited; consult a qualified professional if you take medication or have a health condition.
BPC-157 Benefits & Uses
Where BPC-157 is commonly discussed - with research-first language and conservative expectations.
Recovery Pathways
Studied in preclinical tendon, ligament, and tissue-stress models.
Learn more
BPC-157 appears across preclinical literature discussing tendon outgrowth, ligament recovery markers, angiogenesis, and nitric-oxide signaling. These findings should be read as research context, not as promised outcomes.
Gut-Lining Models
Oral delivery is a practical route for gut-route exposure.
Learn more
BPC-157 is often discussed around gastric and intestinal models because of its peptide origin. Oral capsules are the simplest format for users focused on gut-route exposure.
Capsule Convenience
500 mcg per capsule with no reconstitution steps.
Learn more
Capsules remove measuring and mixing variables: no bacteriostatic water, no syringe math, no vial handling, and no cold-chain routine.
COA-Verified Raw Material
BT Lab Testing verified identity, purity, and potency.
Learn more
The CoA confirms the BPC-157 raw material used in this lot by FTIR and HPLC, including 100% HPLC purity and 100% potency on the tested material.
This content is educational, not medical advice. Human oral-use data is limited.
How BPC-157 Works
BPC-157 is researched for activity across nitric-oxide signaling, angiogenesis, VEGFR2-Akt-eNOS pathways, and tissue-recovery models.
The compound is discussed in the literature for how it may influence local signaling pathways involved in tissue stress and recovery models. Oral delivery changes the route of exposure versus subcutaneous research protocols, so expectations should remain conservative.
| Form | Solubility | Typical Dose | Onset | Notes |
|---|---|---|---|---|
| Oral capsules | N/A | 500 mcg (1 capsule) | Gradual | Pre-dosed, room-temperature, and easiest for daily use. |
| Reconstituted vial | Protocol-dependent | Research protocol dependent | Route dependent | Requires bacteriostatic water, syringe measurement, and refrigerated handling after reconstitution. |
Informational only. Not medical advice.
How to Use BPC-157 Capsules Responsibly
Start conservatively, keep expectations gradual, and avoid combining with aggressive recovery protocols without qualified guidance.
| Form | Dose Range | Frequency | Onset/Duration |
|---|---|---|---|
| Capsules | 500 mcg | 1x/day | AM or protocol-dependent |
| Cycle | 4-8 weeks | Then break | Individual |
Do
- Start with 1 capsule (500 mcg) daily.
- Store tightly closed at room temperature.
- Track response over 2-4 weeks before changing your protocol.
Don't
- Do not use if pregnant, nursing, or under 18.
- Do not use as a replacement for professional care.
- Do not combine with medication or complex protocols without professional guidance.
Educational only. Not medical advice. BPC-157 is not intended to diagnose, treat, cure, or prevent any disease.
BPC-157 Capsules vs Vials
The same compound can be presented in different formats. Choose based on route, handling, and protocol complexity.
| Option | Mechanism | Best For | Onset | Notes |
|---|---|---|---|---|
| BPC-157 Capsules | Oral route; pre-dosed 500 mcg capsules | Simple daily format and gut-route exposure | Gradual | No reconstitution, no syringes, and room-temperature storage. |
| BPC-157 Vial | Reconstituted peptide format | Advanced research protocols | Route dependent | Requires bacteriostatic water, careful measurement, and refrigerated handling after reconstitution. |
| TB-500 | Thymosin beta-4 fragment | Research stacks focused on systemic recovery models | Protocol dependent | Often discussed alongside BPC-157 in peptide research contexts. |
Evidence Snapshot
BPC-157 has a broad preclinical literature base across tendon, ligament, gut-lining, angiogenesis, and inflammatory-response models. Human oral-use evidence remains limited.
- PubMed — Tendon outgrowth model
- PubMed — Gut-lining / mucosa models
- PubMed — Ligament recovery markers
- PubMed — Angiogenesis / NO signaling
Educational only; not medical advice.
Shop BPC-157
Pre-dosed oral capsules with raw-material COA verification by BT Lab Testing.
BPC-157 500mcg Capsules
375.00 AED
Unit price
Regular price
per
New
Frequently Asked Questions
Is oral BPC-157 the same compound as the vial?
Yes. It is the same BPC-157 compound, presented as a 500 mcg oral capsule rather than a reconstituted vial format.
Does it need refrigeration?
No. Store the bottle tightly closed at room temperature, away from heat, moisture, and direct light.
What does the CoA verify?
The BT Lab Testing CoA verifies the identity, 100% HPLC purity, and 100% potency of the BPC-157 raw material used in this lot.
How many capsules are in the bottle?
Each bottle contains 60 capsules at 500 mcg BPC-157 per capsule.
How should I think about oral versus subcutaneous protocols?
The route of exposure is different. Oral capsules prioritize simplicity and gut-route exposure; subcutaneous vial protocols are more complex and discussed separately in research contexts.
BPC-157, now in simple 500 mcg capsules.
60-count bottle - Raw-material COA verified - Room-temperature storage - Fast Dubai and worldwide shipping
Ships today from Dubai - order by 6pm